Published in Biochem J on January 01, 1978
Core glycosylation of collagen is initiated by two beta(1-O)galactosyltransferases. Mol Cell Biol (2008) 1.15
Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. Biochem J (1979) 1.08
The biosynthesis of collagen. Annu Rev Biochem (1974) 2.50
Isolation of a collagen from basement membranes containing three identical - chains. Biochem Biophys Res Commun (1971) 2.17
Characterization and quantitative determination of the hydroxylysine-linked carbohydrate units of several collagens. J Biol Chem (1969) 1.58
The structure of the disaccharide unit of the renal glomerular basement membrane. J Biol Chem (1967) 1.51
Biosynthesis of collagen and its alterations in pathological states. Med Biol (1976) 1.42
Some kinetic properties of human-milk galactosyl transferase. Eur J Biochem (1974) 1.39
Assay of collagen-galactosyltransferase and collagen-glucosyltransferase activities and preliminary characterization of enzymic reactions with transferases from chick-embryo cartilage. Eur J Biochem (1975) 1.32
Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interaction. Biochemistry (1976) 1.25
Biochemical properties of human glomerular basement membrane in normal and diabetic kidneys. J Clin Invest (1974) 1.23
Biosynthesis of chondroitin sulfate. Solubilization of chondroitin sulfate glycosyltransferases and partial purification of uridine diphosphate-D-galactose:D-xylose galactosyltrans. J Biol Chem (1975) 1.09
Lysyl hydroxylase. Further purification and characterization of the enzyme from chick embryos and chick embryo cartilage. Biochim Biophys Acta (1976) 1.06
Hydroxylation of lysine and glycosylation of hydroxylysine during collagen biosynthesis in isolated chick-embryo cartilage cells. Biochem J (1976) 1.03
The intracellular location of the glycosylation of hydroxylysine of collagen. Biochem Biophys Res Commun (1975) 1.03
Affinity chromatography of lysyl hydroxylase on concanavalin A-agarose. Biochim Biophys Acta (1977) 0.98
Affinity chromatography of collagen glucosyltransferase on a UDP-glucose derivative coupled to agarose. Biochim Biophys Acta (1976) 0.96
Metal ion activation of galactosyltransferase. J Biol Chem (1976) 0.95
The function of bivalent metal ions in the reaction catalysed by ATP:creatine phosphotransferase. Biochim Biophys Acta (1966) 0.94
A new rapid method for measuring hydroxylysine and its glycosides in hydrolysates and physiological fluids. Biochim Biophys Acta (1973) 0.93
Partial purification and characterization of collagen galactosyltransferase from chick embryos. Biochem J (1976) 0.93
Concanavalin A binds of purified prolyl hydroxylase and partially inhibits its enzymic activity. Biochem Biophys Res Commun (1976) 0.90
Hydrophobic and carbohydrate-recognition chromatographies of collagen glucosyltransferase. Eur J Biochem (1977) 0.89
Studies on the biosynthesis of the hydroxylsine-linked disaccharide unit of basement membranes and collagens. II. Kidney galactosyltransferase. J Biol Chem (1971) 0.89
Affinity chromatography of collagen glycosyltransferases on collagen linked to agarose. Eur J Biochem (1976) 0.89
Glycoprotein biosynthesis: the biosynthesis of the hydroxylysine-galactose linkage in collagen. Biochem Biophys Res Commun (1968) 0.89
Isolation of collagen glucosyltransferase as a homogeneous protein from chick embryos. Biochim Biophys Acta (1977) 0.86
Isolation and structure determination of glucosylgalactosylhydroxylysine from sponge and sea anemone collagen. Biochemistry (1972) 0.84
The lens capsule. Studies on the carbohydrate units. J Biol Chem (1969) 0.83
On predicting the results of affinity procedures. Methods Enzymol (1974) 0.81
Studies on the mechanism of collagen glucosyltransferase reaction. Eur J Biochem (1976) 0.77
Developmental changes in collagen glycosyltransferase activities in chick embryos. Biochim Biophys Acta (1977) 0.77
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem (1990) 2.51
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem (1993) 2.44
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr (1998) 1.94
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology (1990) 1.56
Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol (1998) 1.53
Biosynthesis of collagen and its alterations in pathological states. Med Biol (1976) 1.42
Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol (1997) 1.40
Laminin. Methods Enzymol (1982) 1.37
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer (1992) 1.34
Assay of collagen-galactosyltransferase and collagen-glucosyltransferase activities and preliminary characterization of enzymic reactions with transferases from chick-embryo cartilage. Eur J Biochem (1975) 1.32
Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol (1995) 1.27
Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest (1985) 1.22
Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem (1996) 1.22
Synthesis of type I collagen in healing wounds in humans. Ann Surg (1991) 1.19
Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest (1988) 1.19
Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J (1990) 1.12
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone (2000) 1.12
Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes. Biochem J (1981) 1.10
Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings. Surgery (1990) 1.08
A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol (1992) 1.07
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. Br J Cancer (1995) 1.06
Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis (1993) 1.05
Analysis of extracellular matrix proteins in biological fluids. Methods Enzymol (1987) 1.04
Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer (1995) 1.04
Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus. Am J Pathol (1993) 1.04
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer (1996) 1.03
Glucosylation of galactosylhydroxylysyl residues in collagen in vitro by collagen glucosyltransferase. Inhibition by triple-helical conformation of the substrate. Eur J Biochem (1975) 1.03
Collagen glucosyltransferase. Partial purification and characterization of the enzyme from whole chick embryos and chick-embryo cartilage. Eur J Biochem (1976) 1.03
Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol (1992) 1.03
Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect. Br J Dermatol (1994) 1.02
Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol (1993) 0.99
Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res (1993) 0.98
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up. Br J Rheumatol (1994) 0.98
Basal lamina glycoproteins laminin and type IV collagen are assembled into a fine-fibered matrix in cultures of a teratocarcinoma-derived endodermal cell line. Exp Cell Res (1982) 0.97
Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator. Am Heart J (1996) 0.97
Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res (1991) 0.97
Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br J Dermatol (1997) 0.95
Purification and characterization of the N-terminal propeptide of human type III procollagen. Biochem J (1985) 0.95
Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis (1993) 0.95
Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab (1994) 0.94
The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism. Cancer (1987) 0.93
Partial purification and characterization of collagen galactosyltransferase from chick embryos. Biochem J (1976) 0.93
Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum. Clin Chim Acta (1982) 0.93
Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology (1996) 0.92
Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients. J Neurosci Res (1992) 0.92
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group. Eur J Cancer (1993) 0.92
Aminoterminal propeptide of type III procollagen in healing wound in humans. Ann Surg (1987) 0.92
Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med (1994) 0.91
Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Gastroenterology (1983) 0.91
Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis (1995) 0.91
Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res (1992) 0.91
Glial cells of mammalian brain produce a variant form of laminin. Exp Neurol (1989) 0.90
Immunohistochemical evidence that lung carcinomas grow on alveolar basement membranes. Am J Surg Pathol (1990) 0.89
Affinity chromatography of collagen glycosyltransferases on collagen linked to agarose. Eur J Biochem (1976) 0.89
Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology (1992) 0.89
Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand Suppl (1995) 0.88
Formation of osteoblast-like cells from human mononuclear bone marrow cultures. APMIS (1991) 0.88
Type I collagen metabolites as tumor markers in patients with lung carcinoma. Cancer (1999) 0.88
Connective tissue response to major surgery and postoperative infection. Eur J Clin Invest (1992) 0.87
Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis. Ann Rheum Dis (1991) 0.87
Complete processing of type III collagen in atherosclerotic plaques. Arterioscler Thromb Vasc Biol (1999) 0.87
Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP). Br J Haematol (1992) 0.86
Immunoelectron microscopic localization of laminin, type IV collagen, and type III pN-collagen in reticular fibers of human lymph nodes. J Histochem Cytochem (1989) 0.86
Increased type I collagen degradation in early rheumatoid arthritis. J Rheumatol (1994) 0.86
Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer. Clin Cancer Res (1999) 0.86
Isolation of collagen glucosyltransferase as a homogeneous protein from chick embryos. Biochim Biophys Acta (1977) 0.86
Incorporation of sulphate into type III procollagen by cultured human fibroblasts. Identification of tyrosine O-sulphate. Eur J Biochem (1986) 0.86
Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresia. Pediatr Res (1995) 0.86
Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int (1986) 0.85
Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br J Haematol (1986) 0.85
Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP. Cancer Res (1997) 0.85
Intracellular enzymes of collagen biosynthesis in 3T6 fibroblasts and chick-embryo tendon and cartilage cells. Eur J Biochem (1979) 0.85
Characterization of the perivascular reticulin network in a case of primary brain lymphoma. Immunohistochemical demonstration of collagen types I, III, IV, and V; laminin; and fibronectin. Acta Neuropathol (1985) 0.85
Increased amount of type III pN-collagen in human abdominal aortic aneurysms: evidence for impaired type III collagen fibrillogenesis. J Vasc Surg (2000) 0.85
Laminin and type IV collagen in different histological stages of Kaposi's sarcoma and other vascular lesions of blood vessel or lymphatic vessel origin. Am J Surg Pathol (1988) 0.85
Serum type I procollagen peptide: a non-invasive index of bone formation in patients on haemodialysis? Nephrol Dial Transplant (1994) 0.85
Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo. Br J Cancer (1999) 0.84
Increased collagen synthesis in psoriasis in vivo. Arch Dermatol Res (1995) 0.84
The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism (1991) 0.84
Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells. J Cell Biochem (1998) 0.84
Effects of experimental nephrosis on basement-membrane components and enzymes of collagen biosynthesis in rat kidney. Biochem J (1985) 0.84
Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut (1996) 0.84
Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquamous carcinomas of the skin: an immunohistochemical study with human laminin and type IV collagen antibodies. J Invest Dermatol (1984) 0.84
Effect of the structural components of basement membranes on the attachment of teratocarcinoma-derived endodermal cells. Exp Cell Res (1983) 0.84
Low synthesis rate of type I procollagen is normalized during active back rehabilitation. Spine (Phila Pa 1976) (1997) 0.84
Amino-terminal propeptide of type III procollagen: a new prognosis indicator in human ovarian cancer. Cancer Res (1989) 0.84
Type I and III collagens in human colon cancer and diverticulosis. Scand J Gastroenterol (2000) 0.84
Basement membrane laminin and type IV collagen in various benign and malignant adnexal tumors of the skin: an immunohistochemical study. J Invest Dermatol (1984) 0.83
Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen. J Pediatr (1989) 0.83
Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung disease. Clin Appl Thromb Hemost (2000) 0.83
Differential processing of type I and type III procollagens in the tumour cysts and peritoneal ascitic fluid of patients with benign and malignant ovarian tumours. Clin Chim Acta (1994) 0.83
Type III collagen metabolism in soft tissue sarcomas. Br J Cancer (1992) 0.83
Biochemical characterization of variants of the Ehlers-Danlos syndrome type VI. Eur J Clin Invest (1983) 0.83